Next Article in Journal
Latest Evidence Regarding the Effects of Photosensitive Drugs on the Skin: Pathogenetic Mechanisms and Clinical Manifestations
Previous Article in Journal
Highly Red Light-Emitting Erbium- and Lutetium-Doped Core-Shell Upconverting Nanoparticles Surface-Modified with PEG-Folic Acid/TCPP for Suppressing Cervical Cancer HeLa Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 12
Issue 11
10.3390/pharmaceutics12111103
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Erratum to Pharmaceutics 2020, 12(10), 940.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Filip, S.; et al. Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 2020, 12, 940

by
Stanislav Filip
1,*,
Ondřej Kubeček
1,
Jiří Špaček
2,
Miriam Lánská
3 and
Milan Bláha
3
1
Department of Oncology and Radiotherapy, Faculty of Medicine in Hradec Králové, Charles University Prague, 50003 Hradec Králové, Czech Republic
2
Department of Gynecology and Obstetrics, Faculty of Medicine in Hradec Králové, Charles University Prague, 50003 Hradec Králové, Czech Republic
3
4th Department of Internal Medicine-Haematology, Faculty Hospital in Hradec Králové, 50005 Hradec Králové, Czech Republic
*
Author to whom correspondence should be addressed.
Pharmaceutics 2020, 12(11), 1103; https://doi.org/10.3390/pharmaceutics12111103
Submission received: 28 October 2020 / Accepted: 6 November 2020 / Published: 17 November 2020
Versions Notes
The following correction has been made to this paper [1]: We would like to inform the readers that our colleague, Jirina Martinkova, asked to be excluded as an author in this communication. Although we regret her decision, we have respectfully fulfilled her request and wish her the best in her future endeavors. All authors accepted this change and signed Change of Authorship Form.

Author Contributions

S.F. and O.K. wrote the article (S.F.–corresponding author), J.Š. consulting of clinical experiences, M.B. and M.L. consulting of plasmafiltration method. All authors have read and agreed to the published version of the manuscript.

Funding

This review was supported by the Ministry of Health CZ, grant number AZV 16-30366A and PROGRES Q40/06.

Conflicts of Interest

The authors declare no conflict of interest.

Reference

  1. Filip, S.; Kubeček, O.; Špaček, J.; Lánská, M.; Bláha, M. Therapeutic apheresis, circulating PLD, and mucocutaneous toxicity: our clinical experience through four years. Pharmaceutics 2020, 12, 940. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Filip, S.; Kubeček, O.; Špaček, J.; Lánská, M.; Bláha, M. Erratum: Filip, S.; et al. Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 2020, 12, 940. Pharmaceutics 2020, 12, 1103. https://doi.org/10.3390/pharmaceutics12111103

AMA Style

Filip S, Kubeček O, Špaček J, Lánská M, Bláha M. Erratum: Filip, S.; et al. Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 2020, 12, 940. Pharmaceutics. 2020; 12(11):1103. https://doi.org/10.3390/pharmaceutics12111103

Chicago/Turabian Style

Filip, Stanislav, Ondřej Kubeček, Jiří Špaček, Miriam Lánská, and Milan Bláha. 2020. "Erratum: Filip, S.; et al. Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 2020, 12, 940" Pharmaceutics 12, no. 11: 1103. https://doi.org/10.3390/pharmaceutics12111103

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop